Skip navigation

Refine by Type

Results 1 - 10 of 10 for Ibrutinib
  1. Ibrutinib is used to treat people with mantle cell lymphoma (a fast-growing cancer that begins in ... treated with at least one other chemotherapy medication. Ibrutinib is in a class of medications called kinase ...
  2. Drugs Approved for Leukemia From the National Institutes of Health (National Cancer Institute)  
    ... Cyclophosphamide) Fludara (Fludarabine Phosphate) Fludarabine Phosphate Gazyva (Obinutuzumab) Ibrutinib Imbruvica (Ibrutinib) Leukeran (Chlorambucil) Linfolizin (Chlorambucil) Neosar (Cyclophosphamide) ...
  3. Drugs Approved for Non-Hodgkin Lymphoma From the National Institutes of Health (National Cancer Institute)  
    ... Methotrexate) Folex PFS (Methotrexate) Folotyn (Pralatrexate) Ibritumomab Tiuxetan Ibrutinib Imbruvica (Ibrutinib) Intron A (Recombinant Interferon Alfa-2b) ...
  4. ... not been targeted before. One of these drugs, ibrutinib (brand name: Imbruvica), has been approved for use ... seen in the majority of patients treated with ibrutinib in trials, with dramatic responses even in heavily ...
  5. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Hyper-CVAD Back to Top I Ibritumomab Tiuxetan Ibrutinib ICE Iclusig (Ponatinib Hydrochloride) Ifex (Ifosfamide) Ifosfamide Ifosfamidum (Ifosfamide) Imatinib Mesylate Imbruvica (Ibrutinib) Imiquimod Inlyta (Axitinib) Intron A (Recombinant Interferon Alfa- ...
  6. American Society of Hematology (American Society of Hematology)  
    ... May 9, 2014 Webinar: ASH/FDA Update on Ibrutinib for Treatment of CLL May 29, 2014 Hematology ...
  7. ... But there is another tyrosine kinase inhibitor, called ibrutinib, that the FDA approved just last month for ...
  8. Mantle Cell Lymphoma (Leukemia & Lymphoma Society) - PDF  
    ... 1101 (CAL-101) and Bruton’s tyrosine kinase inhibitor ibrutinib (PCI-32765). l Monoclonal antibodies –These agents provide ...
  9. ... Administration today expanded the approved use of Imbruvica (ibrutinib) for chronic lymphocytic leukemia (CLL) patients who have ...
  10. ... newly diagnosed patients; the efficacy and safety of ibrutinib is being investigated alone or as part of ...